# Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department

> **NCT03256487** · PHASE2 · UNKNOWN · sponsor: **Alameda Health System** · enrollment: 122 (estimated)

## Conditions studied

- Pain

## Interventions

- **DRUG:** Buprenorphine
- **DRUG:** Morphine Sulfate

## Key facts

- **NCT ID:** NCT03256487
- **Lead sponsor:** Alameda Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-09-26
- **Primary completion:** 2018-02-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 122 (ESTIMATED)
- **Last updated:** 2017-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03256487

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03256487, "Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03256487. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*